Melatonin and Nitrones As Potential Therapeutic Agents for Stroke
Stroke is a disease of aging affecting millions of people worldwide, and recombinant tissue-type plasminogen activator (r-tPA) is the only treatment approved. However, r-tPA has a low therapeutic window and secondary effects which limit its beneficial outcome, urging thus the search for new more eff...
Guardado en:
| Publicado en: | Front Aging Neurosci |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5120103/ https://ncbi.nlm.nih.gov/pubmed/27932976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2016.00281 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Cargando...